ClinicalTrials.gov
ClinicalTrials.gov Menu

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00085332
Recruitment Status : Completed
First Posted : June 11, 2004
Last Update Posted : January 13, 2014
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Gynecologic Oncology Group